Doctor profile · Federal record

Dr. Kathleen Vine, M.D.

Dermatology Physician (CMS: Dermatology) · New York, NY

  • NPI 1659534410
  • Accepts Medicare
  • MIPS 0.0 / 100 · 2023
  • 19 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
928 Broadway, Suite 301
New York, NY 100106008
(646) 421-6064
fax (646) 843-4701
Mailing address
200 E 15Th St Apt 10C
New York, NY 100033960

Credentials & registration

NPPES · NUCC
NPI registered
July 2008 — 18 yrs on file
Profile last updated
June 1, 2016
Year of graduation
2007 — 19 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
New York #262895

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1659534410. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
48,988
Distinct HCPCS
10
Medicare allowed
$1,873,360
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 36,001 116 $2
99214 Established patient office or other outpatient visit, 30-39 minutes 3,987 1,490 $147
17003 Destruction of precancer skin growth, 2-14 growths 2,222 576 $8
17004 Destruction of precancer skin growth, 15 or more growths 2,025 1,014 $202
17000 Destruction of precancer skin growth, 1 growth 948 669 $68
11102 Biopsy of related skin growth, first growth 818 652 $115
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 602 64 $1
99204 New patient office or other outpatient visit, 45-59 minutes 437 436 $193
11103 Biopsy of related skin growth, each additional growth 291 199 $60
96574 Application of light with debridement to destroy precancer skin growth 179 114 $335

In context: peer comparison

Among 139 peers in this city , average services per provider: 182. This provider delivers 269× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,773
Transactions
85
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 17 $211.55
Lilly USA, LLC 8 $192.89
Arcutis Biotherapeutics, Inc. 8 $182.99
ABBVIE INC. 10 $182.34
Janssen Biotech, Inc. 9 $159.82
Incyte Corporation 5 $126.31
SUN PHARMACEUTICAL INDUSTRIES INC. 4 $107.74
UCB, Inc. 4 $98.84
Dermavant Sciences, Inc. 4 $90.26
E.R. Squibb & Sons, L.L.C. 3 $76.92
Biofrontera Inc. 4 $73.96
Amgen Inc. 3 $65.10
Almirall LLC 3 $60.50
Ortho Dermatologics, a division of Bausch Health US, LLC 2 $51.32
Regeneron Healthcare Solutions, Inc. 1 $30.15

By nature of payment

Food and Beverage
$1,773

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
962
Patients
696
Total drug cost
$120,053
Drug Type Claims Patients Total cost
Gentamicin Sulfate Generic 147 119 $6,856
Mupirocin Generic 135 103 $958
Triamcinolone Acetonide Generic 119 97 $2,152
Clobetasol Propionate Generic 112 72 $6,963
Doxycycline Hyclate Generic 102 82 $2,347
Ciclopirox (Ciclopirox Olamine) Brand 58 48 $1,939
Ammonium Lactate Generic 54 36 $1,380
Fluorouracil Generic 47 36 $3,394
Valacyclovir (Valacyclovir Hcl) Brand 47 34 $697
Permethrin Generic 32 14 $1,503

Frequently asked questions

Auto-generated from federal data
What is Dr. Kathleen Vine's medical specialty?
Dr. Kathleen Vine practices Dermatology Physician in New York, NY.
Where does Dr. Kathleen Vine practice?
Dr. Kathleen Vine practices at 928 Broadway, New York, NY 100106008. Office phone: 6464216064.
What is Dr. Kathleen Vine's NPI?
Dr. Kathleen Vine's National Provider Identifier (NPI) is 1659534410, issued by NPPES.
Does Dr. Kathleen Vine accept Medicare assignment?
Yes. Dr. Kathleen Vine accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kathleen Vine commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.